However, JAK-2 was suggested as mediating the signalling pathway of inflammatory cytokines (i.e.: IL 6) [47] and anti-JAK-2 inhibitors are suggested for use to mitigate SARs-CoV-2 infection [48,49]. Here, JAK2 is linked to COVID-19.